Po-Chun Chen, Janet Pham, Sara Huerta-Yepez, Tiran Sargsyan, Jillian Poulsen, Sonia Virk, Tu Nguyen, Steven S Raman, Anahid Jewett, Jason Chiang
{"title":"High-Intensity thermal stress enhances adoptive NK-cell cytotoxicity in poorly differentiated hepatocellular carcinoma.","authors":"Po-Chun Chen, Janet Pham, Sara Huerta-Yepez, Tiran Sargsyan, Jillian Poulsen, Sonia Virk, Tu Nguyen, Steven S Raman, Anahid Jewett, Jason Chiang","doi":"10.1080/02656736.2026.2685850","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Percutaneous thermal ablation is used to treat early-stage, non-resectable hepatocellular carcinoma (HCC). NK-cell immunotherapy has been studied as an adjuvant treatment, but the efficacy remains unclear when combined with ablation.</p><p><strong>Purpose: </strong>To evaluate the potential of peri-ablational, high-intensity thermal stress to augment adoptive NK-cell cytotoxicity in HCC.</p><p><strong>Methods: </strong>HCC cells were exposed to 37, 43, and 47 °C in water baths to recapitulate peri-ablational heat stress before delivering NK-cell therapy. <i>In vitro</i> cytolysis was measured using chromium release and live-cell imaging assays. An orthotopic mouse model of poorly differentiated HCC was used to evaluate the therapeutic effect of combined microwave ablation (MWA) and adoptive NK-cell therapy. Tumor burden was compared via tumor weight, Gaussia luciferase levels, and immunohistochemistry.</p><p><strong>Results: </strong>NK-cell cytotoxicity increased against poorly differentiated HCC cells pretreated at 47 °C compared with 37 °C controls (<i>p</i> < 0.001). <i>In vivo</i>, MWA+NK-cell therapy reduced poorly differentiated HCC weight (1.53 ± 0.44 g) compared to monotherapy groups (MWA: 2.06 ± 0.61; NK: 1.92 ± 0.75 g), although the difference was only found to be significant when compared to untreated tumor group (2.89 ± 0.92 g, <i>p</i> < 0.01). Additionally, MWA+NK-cell therapy significantly decreased Gaussia luciferase level (<i>p</i> < 0.05) and Ki-67 expression (<i>p</i> < 0.01), while increasing tumor necrosis (<i>p</i> < 0.05) in tumors when compared to tumor control.</p><p><strong>Conclusion: </strong>High intensity thermal stress increased susceptibility of poorly differentiated HCC to NK-cell-mediated cytotoxicity <i>in vitro</i> and <i>in vivo</i> when compared to untreated controls. The combination of thermal ablation and adoptive NK-cell therapy should be further investigated in clinically relevant sub-lethal ablation settings and broader ablation-time combinations to support future clinical studies.</p>","PeriodicalId":520653,"journal":{"name":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group","volume":"43 1","pages":"2685850"},"PeriodicalIF":3.0000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/02656736.2026.2685850","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/18 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Percutaneous thermal ablation is used to treat early-stage, non-resectable hepatocellular carcinoma (HCC). NK-cell immunotherapy has been studied as an adjuvant treatment, but the efficacy remains unclear when combined with ablation.
Purpose: To evaluate the potential of peri-ablational, high-intensity thermal stress to augment adoptive NK-cell cytotoxicity in HCC.
Methods: HCC cells were exposed to 37, 43, and 47 °C in water baths to recapitulate peri-ablational heat stress before delivering NK-cell therapy. In vitro cytolysis was measured using chromium release and live-cell imaging assays. An orthotopic mouse model of poorly differentiated HCC was used to evaluate the therapeutic effect of combined microwave ablation (MWA) and adoptive NK-cell therapy. Tumor burden was compared via tumor weight, Gaussia luciferase levels, and immunohistochemistry.
Results: NK-cell cytotoxicity increased against poorly differentiated HCC cells pretreated at 47 °C compared with 37 °C controls (p < 0.001). In vivo, MWA+NK-cell therapy reduced poorly differentiated HCC weight (1.53 ± 0.44 g) compared to monotherapy groups (MWA: 2.06 ± 0.61; NK: 1.92 ± 0.75 g), although the difference was only found to be significant when compared to untreated tumor group (2.89 ± 0.92 g, p < 0.01). Additionally, MWA+NK-cell therapy significantly decreased Gaussia luciferase level (p < 0.05) and Ki-67 expression (p < 0.01), while increasing tumor necrosis (p < 0.05) in tumors when compared to tumor control.
Conclusion: High intensity thermal stress increased susceptibility of poorly differentiated HCC to NK-cell-mediated cytotoxicity in vitro and in vivo when compared to untreated controls. The combination of thermal ablation and adoptive NK-cell therapy should be further investigated in clinically relevant sub-lethal ablation settings and broader ablation-time combinations to support future clinical studies.
背景:经皮热消融用于治疗早期不可切除的肝细胞癌(HCC)。nk细胞免疫治疗作为辅助治疗已被研究,但与消融联合治疗的疗效尚不清楚。目的:评估消融期高强度热应激对肝癌细胞过继性nk细胞毒性的影响。方法:在给予nk细胞治疗之前,将HCC细胞暴露于37、43和47°C的水浴中以重现消融周热应激。体外细胞溶解用铬释放和活细胞成像测定。采用原位低分化肝癌小鼠模型,评价微波消融(MWA)联合nk细胞过继治疗的疗效。通过肿瘤重量、高斯荧光素酶水平和免疫组织化学比较肿瘤负荷。结果:与37°C对照相比,nk细胞对47°C预处理的低分化HCC细胞的细胞毒性增加(p)。在体内,与单一治疗组相比,MWA+ nk细胞治疗减少了低分化HCC的重量(1.53±0.44 g) (MWA: 2.06±0.61;NK: 1.92±0.75 g),但只有与未经治疗的肿瘤组(2.89±0.92 g, p p p p p)相比,差异才有统计学意义。结论:与未经治疗的对照组相比,高强度热应激增加了低分化HCC对NK细胞介导的细胞毒性的体外和体内易感性。在临床相关的亚致死消融环境和更广泛的消融时间组合中,应进一步研究热消融和过过性nk细胞治疗的组合,以支持未来的临床研究。